Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | NPC1 | O15118 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.59 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.59 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.55 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.49 |
| ▸ | PARP1 | P09874 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.48 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30659509 | 1.00 | KMT2A (0.66) | KMT2ANPC1MEN1RAB9APKM | |
| SCHEMBL7079612 | 0.86 | KMT2A (0.65) | KMT2ANPC1MEN1RAB9APKM | |
| SCHEMBL17200636 | 0.84 | NPC1 (0.60) | KMT2ANPC1MEN1RAB9APKM | |
| SCHEMBL28639316 | 0.81 | TLR7 (0.71) | KMT2ANPC1MEN1RAB9APKM | |
| SCHEMBL23572370 | 0.81 | KMT2A (0.73) | KMT2ANPC1MEN1RAB9APKM | |
| SCHEMBL1156133 | 0.81 | KMT2A (0.72) | KMT2ANPC1MEN1RAB9AAGTR1 | |
| SCHEMBL12441772 | 0.80 | KMT2A (0.66) | KMT2ANPC1MEN1RAB9APKM | |
| SCHEMBL8586217 | 0.80 | KMT2A (0.66) | KMT2ANPC1MEN1RAB9APKM | |
| SCHEMBL3836551 | 0.80 | KMT2A (0.66) | KMT2ANPC1RAB9APKMHSD17B14 | |
| SCHEMBL22172012 | 0.80 | KMT2A (0.71) | KMT2ANPC1MEN1RAB9APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12302745-B2 | Tetradentate metal complexes with carbon group bridging ligands | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-05-13 | — | — | US | disclosed |
| US-11958870-B2 | Spiro-containing platinum(II) emitters with tunable emission energies and syntheses thereof | THE UNIVERSITY OF HONG KONG (CN) | 2024-04-16 | — | — | US | disclosed |
| CN-111788212-B | Spiro-containing platinum (II) emitters with adjustable emission energy and synthesis thereof | 香港大学 | 2023-11-10 | — | — | CN | disclosed |
| US-20230255101-A1 | Tetradentate Metal Complexes with Carbon Group Bridging Ligands | UNIV ARIZONA STATE (US) | 2023-08-10 | — | — | US | disclosed |
| US-20230255101-A1 | Tetradentate Metal Complexes with Carbon Group Bridging Ligands | UNIV ARIZONA STATE (US) | 2023-08-10 | — | — | US | disclosed |
| US-20230255101-A1 | Tetradentate Metal Complexes with Carbon Group Bridging Ligands | UNIV ARIZONA STATE (US) | 2023-08-10 | — | — | US | disclosed |
| US-11653560-B2 | Tetradentate metal complexes with carbon group bridging ligands | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-05-16 | — | — | US | disclosed |
| US-11653560-B2 | Tetradentate metal complexes with carbon group bridging ligands | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-05-16 | — | — | US | disclosed |
| US-11653560-B2 | Tetradentate metal complexes with carbon group bridging ligands | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-05-16 | — | — | US | disclosed |
| CN-113402561-A | High-color-purity platinum (II) complex luminescent material based on spirofluorene structure and application thereof | 浙江工业大学 | 2021-09-17 | — | — | CN | disclosed |
| WO-2015149677-A1 | PLATINUM (II) EMITTERS FOR OLED APPLICATIONS | VERSITECH LIMITED (CN) | 2015-10-08 | — | — | WO | disclosed |
| US-20150287937-A1 | PLATINUM (II) EMITTERS FOR OLED APPLICATIONS | VERSITECH LIMITED (HK) | 2015-10-08 | — | — | US | disclosed |
| US-20150287937-A1 | PLATINUM (II) EMITTERS FOR OLED APPLICATIONS | VERSITECH LIMITED (HK) | 2015-10-08 | — | — | US | disclosed |
| US-20130168656-A1 | CYCLOMETALLATED TETRADENTATE PLATINUM COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2013-07-04 | — | — | US | disclosed |
| US-20130168656-A1 | CYCLOMETALLATED TETRADENTATE PLATINUM COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2013-07-04 | — | — | US | disclosed |
| US-20130168656-A1 | CYCLOMETALLATED TETRADENTATE PLATINUM COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2013-07-04 | — | — | US | disclosed |
| US-20030229079-A1 | 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof | PAYNE LINDA S (US) | 2003-12-11 | — | — | US | disclosed |
| EP-1196384-A4 | 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF | MERCK & CO INC (US) | 2002-10-23 | — | — | EP | disclosed |
| EP-1196384-A1 | 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF | Merck & Co., Inc. (US) | 2002-04-17 | — | — | EP | disclosed |
| WO-2001000578-A1 | 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF | MERCK & CO., INC. (US) | 2001-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229079-A1 | 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof | CYP2S1, IMPDH1, IDO1 | KMT2A 3589/4885NPC1 1031/4885MEN1 4377/4885 |
| US-20230255101-A1 | Tetradentate Metal Complexes with Carbon Group Bridging Ligands | STAU1, POLR1G, CLTC | KMT2A 4092/4885NPC1 3632/4885MEN1 1371/4885 |
| US-11958870-B2 | Spiro-containing platinum(II) emitters with tunable emission energies and syntheses thereof | TIMCC, CROCC, DCX | KMT2A 4318/4885NPC1 3876/4885MEN1 2502/4885 |
| US-11653560-B2 | Tetradentate metal complexes with carbon group bridging ligands | PDCD2L, STAU1, POLR1G | KMT2A 4071/4885NPC1 3879/4885MEN1 1103/4885 |
| US-12302745-B2 | Tetradentate metal complexes with carbon group bridging ligands | OCIAD1, OCIAD2, POF1B | KMT2A 4725/4885NPC1 1548/4885MEN1 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.